COL7A1-engineered autologous epidermal stem cells (Gecell Therapeutics/Chinese Academy of Medical Sciences and Peking Union Medical College)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCOL7A1-engineered autologous epidermal stem cells (Gecell Therapeutics/Chinese Academy of Medical Sciences and Peking Union Medical College)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Epidermal stem cell therapy
Mechanisms of ActionCOL7A1 gene transference
TargetsCollagen alpha-1(VII) chain
Therapy Area/IndicationsEpidermolysis Bullosa Dystrophica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Medical Science & Peking Union Medical College
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa Dystrophica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A